NCT04706130

Rigorous Assessment of P. Vivax Relapses and Primaquine Efficacy for Radical Cure

CompletedPHASE4INTERVENTIONAL

Trial Details

Start: 2021-04-15Est. Completion: 2024-10-01

Enrollment target: 160 participants

Locations

Malaria

Background: Malaria is a disease caused by parasites transmitted to people by mosquitoes. Around the world, there were …

Bethesda, United StatesEst. completion Nov 26, 2027

Plasmodium Vivax MalariaMalaria

FLAME is an open-label cluster-randomized controlled trial that aims to determine the effectiveness of focal mass drug a…

Iquitos, PeruEst. completion May 1, 2027

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.